E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/24/2006 in the Prospect News Biotech Daily.

LabCorp third-quarter cash flow $155 million, announces stock repurchase plan

By Lisa Kerner

Charlotte, N.C., Oct. 24 - Laboratory Corp. of America Holdings (LabCorp) saw its cash flow reach $155 million and earnings per share increase 20% for the third quarter ended Sept. 30.

The company ended the quarter with cash and short-term investments of $320.7 million, according to a company news release.

In addition to announcing its quarterly results, LabCorp said a newly authorized stock repurchase program allows the company to purchase up to $500 million of its common stock. This is in addition to LabCorp's current remaining authorization of $100 million.

Net earnings for the quarter were up 12% at $112.9 million during the third quarter from third-quarter 2005 net earnings of $100.7 million. Earnings per share increased 20% to $0.84 from $0.70 per share in the prior-year period.

LabCorp's net sales rose 6.7% to $909.9 million for the quarter, compared with the same period in 2005.

For the nine-month period ended Sept. 30, the company's net earnings increased to $331.2 million from $306.4 million for the same period in 2005. Earnings per share were up 15% to $2.46 for the period from $2.14 in the first nine-months of 2005.

Net sales of $2.69 billion were up 7.5% compared with the year-ago period.

Operating cash flow for the first nine months of the year of $462.1 million was up from $413.0 million in the same period in 2005.

LabCorp updated guidance for 2006 including revenue growth of 6.5% to 7.2%, earnings per share of between $3.28 and $3.33, operating cash flow of about $610 million to $630 million and capital expenditures of about $90 million to $100 million.

For 2007, the company expects revenue growth of 11% to 13% and earnings per share in the range of $3.68 and $3.83.

LabCorp is a medical diagnostic technologies company located in Burlington, N.C.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.